Molecular markers of relapse and treatment response in ovarian cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1023952

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Ovarian cancer is a complex disease with generally poor long-term survival. Response to initial treatment is generally high however most women relapse, usually within 2 years. Response to chemotherapy is variable and difficult to predict. This project will focus on why ovarian cancer recurs, especially after a good initial response; on understanding what features determine response to chemotherapy once patients have relapsed; and on strategies to increase response to chemotherapy.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $539,535.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chemotherapy | cohort study | molecular oncology | mutation analysis | ovarian cancer | platinum drugs | relapse

Related Links